Ahad Amer Alsaiari

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 42

Top Topics

Molecular Docking

Metastatic Colorectal Cancer

Top Venues

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

Medicina (Kaunas, Lithuania)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ahad Amer Alsaiari, Amal F Gharib, Maha Mahfouz Bakhuraysah, Amani A Alrehaili, Shatha M Algethami, Hayfa Ali Alsaif, Norah Al Harthi, Mohammed Ageeli Hakami
Chlordiazepoxide against signalling, receptor and regulatory proteins of breast cancer: a structure-based in-silico approach. Medical oncology (Northwood, London, England) 41 (5) (2024)
Mohammed Ageeli Hakami, Ali Hazazi, Fawaz Albloui, Amal F Gharib, Fouzeyyah Ali Alsaeedi, Osama Abdulaziz, Abdulfattah Yahya M Alhazmi, Ahad Amer Alsaiari
Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid's Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations. International journal of molecular sciences 25 (1) (2024)
Ahad Amer Alsaiari, Amal F Gharib, Maha Mahfouz Bakhuraysah, Amani A Alrehaili, Shatha M Algethami, Hayfa Ali Alsaif, Norah Al Harthi, Mohammed Ageeli Hakami
Chlordiazepoxide against signalling, receptor and regulatory proteins of breast cancer: a structure-based in-silico approach. Medical oncology (Northwood, London, England) 41 (5) (2024)
Mohammed Ageeli Hakami, Ali Hazazi, Mishal Olayan Alsulami, Ahad Amer Alsaiari
Mitoxantrone 2HCl's adroit activity against cervical cancer replication and maintenance proteins: a multitargeted approach. Journal of biomolecular structure & dynamics (2024)
Mohammed Ageeli Hakami, Ali Hazazi, Fawaz Albloui, Amal F Gharib, Fouzeyyah Ali Alsaeedi, Osama Abdulaziz, Abdulfattah Yahya M Alhazmi, Ahad Amer Alsaiari
Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid's Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations. International journal of molecular sciences 25 (1) (2024)
Mohammed Ageeli Hakami, Ali Hazazi, Fawaz Albloui, Amal F Gharib, Fouzeyyah Ali Alsaeedi, Osama Abdulaziz, Abdulfattah Yahya M Alhazmi, Ahad Amer Alsaiari
Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid's Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations. International journal of molecular sciences 25 (1) (2024)
Ahad Amer Alsaiari, Amal F Gharib, Maha Mahfouz Bakhuraysah, Amani A Alrehaili, Shatha M Algethami, Hayfa Ali Alsaif, Norah Al Harthi, Mohammed Ageeli Hakami
Chlordiazepoxide against signalling, receptor and regulatory proteins of breast cancer: a structure-based in-silico approach. Medical oncology (Northwood, London, England) 41 (5) (2024)
Mohammad Habibur Rahman Molla, Mohammed Othman Aljahdali, Md Afsar Ahmed Sumon, Amer H Asseri, Hisham N Altayb, Md Shafiqul Islam, Ahad Amer Alsaiari, F A Dain Md Opo, Nushrat Jahan, Foysal Ahammad, Farhan Mohammad
Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Tafadzwa Dzinamarira, Mazen M Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Abdulaziz Alsharif, Abida Khan, Mehnaz Kamal, Ali A Rabaan, Amal H Alfaraj, Bashayer M AlShehail, Nouf E Alotaibi, Shams M AlShehail, Mohd Imran
Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Mazen M Almehmadi, Ihtisham Ul Haq, Ahad Amer Alsaiari, Fahad M Alshabrmi, Osama Abdulaziz, Mamdouh Allahyani, Mohammed Aladhadh, Alaa Shafie, Abdulelah Aljuaid, Rema Turki Alotaibi, Jawad Ullah, Nada Saud Alharthi
Identification of Small Molecule Inhibitors of Human Cytomegalovirus pUL89 Endonuclease Using Integrated Computational Approaches. Molecules (Basel, Switzerland) 28 (9) (2023)
Shuaibu Abdullahi Hudu, Fayig Elmigdadi, Aiman Al Qtaitat, Mazen M Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Magdi Mansour Salih, Adel Alghamdi, Mohammad A Alrofaidi, Abida Khan, Mohd Imran
Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need. Journal of clinical medicine 12 (15) (2023)
Mansour Almuqbil, Sarah Alshaikh, Nura Alrumayh, Fay Alnahdi, Eiman Fallatah, Shahad Almutairi, Mohd Imran, Mehnaz Kamal, Mazen M Almehmadi, Ahad Amer Alsaiari, Wafa Ali Abdulrhman Alqarni, Ali Mohammed Alasmari, Sara Alwarthan, Ali A Rabaan, Moneer E Almadani, Syed Mohammed Basheeruddin Asdaq
Role of Natural Products in the Management of COVID-19: A Saudi Arabian Perspective. Healthcare (Basel, Switzerland) 11 (11) (2023)
Abdulelah Aljuaid, Mazen Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Osama Abdulaziz, Abdulaziz Alsharif, Jawaher Amer Alsaiari, Magdi Mansour Salih, Rema Turki Alotaibi, Idrees Khan
g-C 3 N 4 Based Photocatalyst for the Efficient Photodegradation of Toxic Methyl Orange Dye: Recent Modifications and Future Perspectives. Molecules (Basel, Switzerland) 28 (7) (2023)
Mohd Imran, null Abida, Nawaf M Alotaibi, Hamdy Khamees Thabet, Jamal Alhameedi Alruwaili, Lina Eltaib, Ahmed Alshehri, Ahad Amer Alsaiari, Mehnaz Kamal, Abdulmajeed Mohammed Abdullah Alshammari
Repurposing Anti-Dengue Compounds against Monkeypox Virus Targeting Core Cysteine Protease. Biomedicines 11 (7) (2023)
null Sadaf, Ali Hazazi, Samia S Alkhalil, Ahad Amer Alsaiari, Amal F Gharib, Hayaa M Alhuthali, Shanika Rana, Abdulaziz A Aloliqi, Alaa Abdulaziz Eisa, Mohammad Raghibul Hasan, Kapil Dev
Role of Fork-Head Box Genes in Breast Cancer: From Drug Resistance to Therapeutic Targets. Biomedicines 11 (8) (2023)
Tian-Meng Cui, Muhammad Altaf, Abdu Aldarhami, Abdulrahman S Bazaid, Nizar Hamed Saeedi, Almohanad A Alkayyal, Fahad M Alshabrmi, Farman Ali, Mohammed Aladhadh, Muhammad Yasir Khan, Ahad Amer Alsaiari, Yue-Rong Ma
Dihydropyrimidone Derivatives as Thymidine Phosphorylase Inhibitors: Inhibition Kinetics, Cytotoxicity, and Molecular Docking. Molecules (Basel, Switzerland) 28 (8) (2023)
Mohd Imran, Mazen M Almehmadi, Ahad Amer Alsaiari, Mehnaz Kamal, Mohammed Kanan Alshammari, Mohammed Omar Alzahrani, Faisal Khaled Almaysari, Abdulrahman Omar Alzahrani, Ahmed Faraj Elkerdasy, Dinesh Kumar Chellapan
Intranasal Delivery of a Silymarin Loaded Microemulsion for the Effective Treatment of Parkinson's Disease in Rats: Formulation, Optimization, Characterization, and In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Tian-Meng Cui, Muhammad Altaf, Abdu Aldarhami, Abdulrahman S Bazaid, Nizar Hamed Saeedi, Almohanad A Alkayyal, Fahad M Alshabrmi, Farman Ali, Mohammed Aladhadh, Muhammad Yasir Khan, Ahad Amer Alsaiari, Yue-Rong Ma
Dihydropyrimidone Derivatives as Thymidine Phosphorylase Inhibitors: Inhibition Kinetics, Cytotoxicity, and Molecular Docking. Molecules (Basel, Switzerland) 28 (8) (2023)
Abdulraheem Ali Almalki, Alaa Shafie, Ali Hazazi, Hamsa Jameel Banjer, Maha M Bakhuraysah, Sarah Abdullah Almaghrabi, Ahad Amer Alsaiari, Fouzeyyah Ali Alsaeedi, Amal Adnan Ashour, Afaf Awwadh Alharthi, Nahed S Alharthi, Farah Anjum
Targeting Cathepsin L in Cancer Management: Leveraging Machine Learning, Structure-Based Virtual Screening, and Molecular Dynamics Studies. International journal of molecular sciences 24 (24) (2023)
Tian-Meng Cui, Muhammad Altaf, Abdu Aldarhami, Abdulrahman S Bazaid, Nizar Hamed Saeedi, Almohanad A Alkayyal, Fahad M Alshabrmi, Farman Ali, Mohammed Aladhadh, Muhammad Yasir Khan, Ahad Amer Alsaiari, Yue-Rong Ma
Dihydropyrimidone Derivatives as Thymidine Phosphorylase Inhibitors: Inhibition Kinetics, Cytotoxicity, and Molecular Docking. Molecules (Basel, Switzerland) 28 (8) (2023)
Mohammad Habibur Rahman Molla, Mohammed Othman Aljahdali, Md Afsar Ahmed Sumon, Amer H Asseri, Hisham N Altayb, Md Shafiqul Islam, Ahad Amer Alsaiari, F A Dain Md Opo, Nushrat Jahan, Foysal Ahammad, Farhan Mohammad
Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Mohd Imran, Mazen M Almehmadi, Ahad Amer Alsaiari, Mehnaz Kamal, Mohammed Kanan Alshammari, Mohammed Omar Alzahrani, Faisal Khaled Almaysari, Abdulrahman Omar Alzahrani, Ahmed Faraj Elkerdasy, Dinesh Kumar Chellapan
Intranasal Delivery of a Silymarin Loaded Microemulsion for the Effective Treatment of Parkinson's Disease in Rats: Formulation, Optimization, Characterization, and In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Tian-Meng Cui, Muhammad Altaf, Abdu Aldarhami, Abdulrahman S Bazaid, Nizar Hamed Saeedi, Almohanad A Alkayyal, Fahad M Alshabrmi, Farman Ali, Mohammed Aladhadh, Muhammad Yasir Khan, Ahad Amer Alsaiari, Yue-Rong Ma
Dihydropyrimidone Derivatives as Thymidine Phosphorylase Inhibitors: Inhibition Kinetics, Cytotoxicity, and Molecular Docking. Molecules (Basel, Switzerland) 28 (8) (2023)
Mazen M Almehmadi, Ihtisham Ul Haq, Ahad Amer Alsaiari, Fahad M Alshabrmi, Osama Abdulaziz, Mamdouh Allahyani, Mohammed Aladhadh, Alaa Shafie, Abdulelah Aljuaid, Rema Turki Alotaibi, Jawad Ullah, Nada Saud Alharthi
Identification of Small Molecule Inhibitors of Human Cytomegalovirus pUL89 Endonuclease Using Integrated Computational Approaches. Molecules (Basel, Switzerland) 28 (9) (2023)
Sahar Rafat, Mohammed Ageeli Hakami, Ali Hazazi, Ahad Amer Alsaiari, Summya Rashid, Mohammad Raghibul Hasan, Abdulaziz A Aloliqi, Alaa Abdulaziz Eisa, Mohammad Irfan Dar, Mohd Faisal Khan, Kapil Dev
Inhibition of Autophagy and the Cytoprotective Role of Smac Mimetic against ROS-Induced Cancer: A Potential Therapeutic Strategy in Relapse and Chemoresistance Cases in Breast Cancer. Current issues in molecular biology 45 (7) (2023)
Mohammad Habibur Rahman Molla, Mohammed Othman Aljahdali, Md Afsar Ahmed Sumon, Amer H Asseri, Hisham N Altayb, Md Shafiqul Islam, Ahad Amer Alsaiari, F A Dain Md Opo, Nushrat Jahan, Foysal Ahammad, Farhan Mohammad
Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Ting-Ting Liu, Yan-Kun Chen, Muhammad Adil, Mazen M Almehmadi, Fahad M Alshabrmi, Mamdouh Allahyani, Ahad Amer Alsaiari, Pei Liu, Muhammad Raheel Khan, Qinghua Peng
In Silico Identification of Natural Product-Based Inhibitors Targeting IL-1β/IL-1R Protein-Protein Interface. Molecules (Basel, Switzerland) 28 (13) (2023)
Mohammad Habibur Rahman Molla, Mohammed Othman Aljahdali, Md Afsar Ahmed Sumon, Amer H Asseri, Hisham N Altayb, Md Shafiqul Islam, Ahad Amer Alsaiari, F A Dain Md Opo, Nushrat Jahan, Foysal Ahammad, Farhan Mohammad
Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Abid Ullah, Shujaat Ahmad, Niaz Ali, Haya Hussain, Mamdouh Allahyani, Mazen M Almehmadi, Ahad Amer Alsaiari, Osama Abdulaziz, Feras Almarshad, Syeda Hajira Bukhari
The Effects of Moxifloxacin and Gemifloxacin on the ECG Morphology in Healthy Volunteers: A Phase 1 Randomized Clinical Trial. Diagnostics (Basel, Switzerland) 13 (7) (2023)
Niaz Ali, Wajid Ali, Abid Ullah, Shujaat Ahmad, Ahad Amer Alsaiari, Mazen M Almehmadi, Osama Abdulaziz, Mamdouh Allahyani, Abdulelah Aljuaid
Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Tafadzwa Dzinamarira, Mazen M Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Abdulaziz Alsharif, Abida Khan, Mehnaz Kamal, Ali A Rabaan, Amal H Alfaraj, Bashayer M AlShehail, Nouf E Alotaibi, Shams M AlShehail, Mohd Imran
Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Mohd Imran, Mazen M Almehmadi, Ahad Amer Alsaiari, Mehnaz Kamal, Mohammed Kanan Alshammari, Mohammed Omar Alzahrani, Faisal Khaled Almaysari, Abdulrahman Omar Alzahrani, Ahmed Faraj Elkerdasy, Dinesh Kumar Chellapan
Intranasal Delivery of a Silymarin Loaded Microemulsion for the Effective Treatment of Parkinson's Disease in Rats: Formulation, Optimization, Characterization, and In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Tafadzwa Dzinamarira, Mazen M Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Abdulaziz Alsharif, Abida Khan, Mehnaz Kamal, Ali A Rabaan, Amal H Alfaraj, Bashayer M AlShehail, Nouf E Alotaibi, Shams M AlShehail, Mohd Imran
Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Niaz Ali, Wajid Ali, Abid Ullah, Shujaat Ahmad, Ahad Amer Alsaiari, Mazen M Almehmadi, Osama Abdulaziz, Mamdouh Allahyani, Abdulelah Aljuaid
Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Mohammad Habibur Rahman Molla, Mohammed Othman Aljahdali, Md Afsar Ahmed Sumon, Amer H Asseri, Hisham N Altayb, Md Shafiqul Islam, Ahad Amer Alsaiari, F A Dain Md Opo, Nushrat Jahan, Foysal Ahammad, Farhan Mohammad
Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Abdulraheem Ali Almalki, Alaa Shafie, Ali Hazazi, Hamsa Jameel Banjer, Maha M Bakhuraysah, Sarah Abdullah Almaghrabi, Ahad Amer Alsaiari, Fouzeyyah Ali Alsaeedi, Amal Adnan Ashour, Afaf Awwadh Alharthi, Nahed S Alharthi, Farah Anjum
Targeting Cathepsin L in Cancer Management: Leveraging Machine Learning, Structure-Based Virtual Screening, and Molecular Dynamics Studies. International journal of molecular sciences 24 (24) (2023)
Mohd Imran, Mazen M Almehmadi, Ahad Amer Alsaiari, Mehnaz Kamal, Mohammed Kanan Alshammari, Mohammed Omar Alzahrani, Faisal Khaled Almaysari, Abdulrahman Omar Alzahrani, Ahmed Faraj Elkerdasy, Dinesh Kumar Chellapan
Intranasal Delivery of a Silymarin Loaded Microemulsion for the Effective Treatment of Parkinson's Disease in Rats: Formulation, Optimization, Characterization, and In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Niaz Ali, Wajid Ali, Abid Ullah, Shujaat Ahmad, Ahad Amer Alsaiari, Mazen M Almehmadi, Osama Abdulaziz, Mamdouh Allahyani, Abdulelah Aljuaid
Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Md Akib Ferdous, Sk Injamamul Islam, Nasim Habib, Mazen M Almehmadi, Mamdouh Allahyani, Ahad Amer Alsaiari, Alaa Shafie
CRISPR-Cas Genome Editing Technique for Fish Disease Management: Current Study and Future Perspective. Microorganisms 10 (10) (2022)
Haya Hussain, Shujaat Ahmad, Syed Wadood Ali Shah, Abid Ullah, Shafiq Ur Rahman, Manzoor Ahmad, Mazen M Almehmadi, Osama Abdulaziz, Mamdouh Allahyani, Ahad Amer Alsaiari, Mustafa Halawi, Edrous Alamer
Synthetic Mono-Carbonyl Curcumin Analogues Attenuate Oxidative Stress in Mouse Models. Biomedicines 10 (10) (2022)
Sk Injamamul Islam, Saloa Sanjida, Sheikh Sunzid Ahmed, Mazen M Almehmadi, Mamdouh Allahyani, Abdulelah Aljuaid, Ahad Amer Alsaiari, Mustafa Halawi
Core Proteomics and Immunoinformatic Approaches to Design a Multiepitope Reverse Vaccine Candidate against Chagas Disease. Vaccines 10 (10) (2022)
Farman Ali Khan, Nasir Mehmood Khan, Shujaat Ahmad, null Nasruddin, Riffat Aziz, Ihsan Ullah, Mazen M Almehmadi, Mamdouh Allahyani, Ahad Amer Alsaiari, Abdulelah Aljuaid
Phytochemical Profiling, Antioxidant, Antimicrobial and Cholinesterase Inhibitory Effects of Essential Oils Isolated from the Leaves of Artemisia scoparia and Artemisia absinthium . Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)